title: [Urinary calculi, consisting of dehydrated calcium phosphate. Clinical, biological, radiologic aspects, clinical course and management].
abstract: Seventeen cases of urinary calculi analyzed by infrared spectrophotometry were found to be composed entirely or nearly entirely of bihydrated calcium hydrophosphate. The observations are summarized here. This type of stone occurs with a frequency of about 1% (0.85% in our experience) of all urinary calculi, predominantly in men (14 of our 17 cases). Diagnosis is based on the physical and chemical analysis of the stone and on infrared spectrophotometry. Most of these stones are pure or nearly pure compounds. The macroscopic aspect of the stones or fragments of stones can guide diagnosis. These stones are cream coloured stones with a smooth regular outer surface. Broken fragments show the same cream colour, sometimes with strips radiating from the centre of the fracture surface. Radiologically, these stones are homogeneously radio-opaque, often oval-shaped with a regular outline. Blood tests can demonstrate suspected or proven hyperparathyroidism (4 out of 10 cases in our 17 observations) with hypercalcemia, hypophosphatemia and hypercalciuria. Complementary examinations may be needed to search for a parathyroid adenoma. With or without hyperparathyroidism, 24-h urinalysis usually shows hypercalciuria up to ro over 500 to 600 mg/24 h. Crystallization usually occurs in the upper urinary tract, in the bladder or in indwelling catheters. These stones are extremely hard and are difficult to break in vitro. To be successful, lithotripsy requires prolonged treatment: up to 3000 to 6000 shockwaves at 22-23 kv with the Dornier apparatus. Despite the notion of hypercalciuria, the pathogenesis of bihydrated calcium hydrophosphate calculi remains to be elucidated.
authors.affiliation: Service d'Andro-Urologie, Hôpital Tenon, Paris.
authors.forename: J
authors.initials: J
authors.lastname: Thomas
authors.forename: E
authors.initials: E
authors.lastname: Thomas
authors.forename: D
authors.initials: D
authors.lastname: Fompeydie
authors.forename: G
authors.initials: G
authors.lastname: Arvis
authors.forename: M
authors.initials: M
authors.lastname: Zerbib
authors.forename: E
authors.initials: E
authors.lastname: Bénassayag
authors.forename: T
authors.initials: T
authors.lastname: Flam
authors.forename: B
authors.initials: B
authors.lastname: Debré
mesh_terms: D000328:Adult; D000368:Aged; D002130:Calcium Phosphates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000737:chemistry / Q000000981:diagnostic imaging / Q000628:therapy*; D008096:Lithotripsy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011859:Radiography; D013055:Spectrophotometry, Infrared; D014514:Ureteral Calculi / Q000737:chemistry / Q000000981:diagnostic imaging / Q000628:therapy*; D001744:Urinary Bladder Calculi / Q000737:chemistry / Q000628:therapy*
chemical_list: D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous
vernacular_title: Lithiase urinaire de brushite. Particularités cliniques, biologiques, radiologiques, évolutives et thérapeutiques.